Regulatory & Strategic Flexibility

 

The therapeutic proposition is grounded on regulatory package of Ubigenine and supramolecular complex thereof. A fast-track clinical operations and market entry relies on a flexible regulatory approach.

​

Besides licensing-out and distribution agreement, we are also open to co-development agreement by single asset, or long-term collaboration on R&D.